Janney Montgomery Scott
SMMT icon

Janney Montgomery Scott’s Summit Therapeutics SMMT Stock Holding History

Janney Montgomery Scott’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
+12,562
New +$223K ﹤0.01% 3007
2025
Q2 		– Sell
-17,610
Closed -$340K – 2818
2025
Q1 		$340K Buy
17,610
+1,894
+12% +$38K ﹤0.01% 2232
2024
Q4 		$280K Buy
15,716
+4,443
+39% +$86.1K ﹤0.01% 2352
2024
Q3 		$247K Buy
+11,273
New +$158K ﹤0.01% 2407

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Janney Montgomery Scott's SMMT Position: Q2 2026 in Review

Janney Montgomery Scott opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 12,562 shares worth $183K. The stake represents ﹤0.01% of the portfolio and ranks #3007 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in SMMT as recently as Q1 2025.

Janney Montgomery Scott first reported a position in SMMT in Q3 2024 and has held it in 4 quarters since. The position peaked at $340K in Q1 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Janney Montgomery Scott held 12,562 shares of Summit Therapeutics worth $183K as of Q2 2026.
  • Summit Therapeutics was a new Janney Montgomery Scott position in Q2 2026.
  • Summit Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #3007 holding.
  • Janney Montgomery Scott first reported a position in Summit Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Janney Montgomery Scott's Summit Therapeutics position peaked at $340K in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.